INmune Bio, Inc.
INMB
$1.96
-$0.02-1.01%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 33.37M | 19.34M | 20.92M | 33.55M | 31.07M |
| Total Receivables | 2.16M | 1.42M | 1.41M | 1.42M | 3.41M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 505.00K | 207.00K | 331.00K | 879.00K | 1.01M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 36.03M | 20.96M | 22.66M | 35.85M | 35.50M |
|
|
|||||
| Total Current Assets | 36.03M | 20.96M | 22.66M | 35.85M | 35.50M |
| Net Property, Plant & Equipment | 1.08M | 278.00K | 307.00K | 335.00K | 363.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | 16.51M | 16.51M | 16.51M | 16.51M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 570.00K | 49.00K | 79.00K | 82.00K | 81.00K |
| Total Assets | 37.68M | 37.80M | 39.56M | 52.78M | 52.45M |
|
|
|||||
| Total Accounts Payable | 7.67M | 7.20M | 6.54M | 10.59M | 9.28M |
| Total Accrued Expenses | 184.00K | -- | 25.00K | 55.00K | 139.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 220.00K | 146.00K | 140.00K | 2.63M | 5.11M |
| Total Finance Division Other Current Liabilities | 511.00K | 583.00K | 517.00K | 549.00K | 521.00K |
| Total Other Current Liabilities | 511.00K | 583.00K | 517.00K | 549.00K | 521.00K |
| Total Current Liabilities | 8.59M | 7.93M | 7.22M | 13.82M | 15.05M |
|
|
|||||
| Total Current Liabilities | 8.59M | 7.93M | 7.22M | 13.82M | 15.05M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 231.00K | 201.00K | 244.00K | 284.00K | 322.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 8.82M | 8.13M | 7.47M | 14.11M | 15.37M |
|
|
|||||
| Common Stock & APIC | 226.93M | 203.13M | 195.78M | 193.60M | 178.79M |
| Retained Earnings | -197.30M | -172.84M | -163.10M | -153.89M | -141.79M |
| Treasury Stock & Other | -763.00K | -610.00K | -575.00K | -1.04M | -713.00K |
| Total Common Equity | 28.87M | 29.67M | 32.10M | 38.68M | 36.28M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | 799.00K |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | 799.00K |
|
|
|||||
| Total Common Equity | 28.87M | 29.67M | 32.10M | 38.68M | 36.28M |
| Total Preferred Equity | -- | -- | -- | -- | 799.00K |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 28.87M | 29.67M | 32.10M | 38.68M | 37.08M |
|
|
|||||